drugset / Trial / NCT05716607
Treatment Study in Patients Treated With Both Insulin & Hydrocortisone
Withdrawn
Vastra Gotaland Region
Pilloxa · collabSahlgrenska University Hospital · collabThe Swedish Society of Medicine · collab
RandomizedCrossoverOpen-labelTreatment
Summary
The aim of INS.CORT trial is, by studying glycemic variability in a well-defined patient group with both insulin \& hydrocortisone (patients with concomitant insulin-treated diabetes \& Addison's disease) and collecting information about the administration -time point and doses- of insulin, hydrocortisone and food intake with the help of new technology to improve the treatment in all patients treated with both insulin \& glucocorticoids.
Timeline
- Start
- 2025-01-01
- Primary completion
- 2026-07-02
- Completion
- 2026-07-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydrocortisone | Other / unclassified | — | — |